Inflammatory Mediator Profiling Reveals Immune Properties of Chemotactic Gradients and Macrophage Mediator Production Inhibition during Thioglycollate Elicited Peritoneal Inflammation

Table 2

Concentrations of inflammatory mediators in exudates and plasma at basal condition in vivo.

	Exudates (A, 𝑛=6)	Plasma (B, 𝑛=8)	Ratio of mean value between A and B on day 0	Ratio on day 1
IP-10	3.05±0.12	44.00±4.88	0.07	0.97
lymphotactin	7.57±0.68	89.50±15.23	0.09	0.40
MIP-2	3.63±0.26	12.59±1.61	0.29	9.75
MCP-3	3.42±0.16	59.50±2.66	0.06	2.26
MCP-5	0.73±0.10	7.83±1.32	0.09	1.29
SCF	119.00±6.88	472.00±39.11	0.25	0.65
TIMP-1	0.20±0.02	0.61±0.05	0.32	5.23
VEGF-A	50.62±12.06	403.50±43.57	0.13	0.87

(1) 𝑃<0.001 between A and B for all groups.
(2) The unit for all concentrations is pg/mL, except TIMP-1 as ng/mL.
(3) The ratio on day 1 is derived from Table 1.